Jailendra Singh Analyst Performance

Managing Director (Senior Equity Research Analyst Covering Healthcare Technology/Digital Health/CROs at Truist Financial

Jailendra Singh is a stock analyst at Truist Financial focused in the medical sector, covering 26 publicly traded companies. Over the past year, Jailendra Singh has issued 34 stock ratings, including buy and hold recommendations. While full access to Jailendra Singh's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jailendra Singh's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 55 Last 5 Years
Buy Recommendations: 50.00% 26 Buy Ratings
Companies Covered: 26 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	50.0%	26 ratings
Hold	48.1%	25 ratings
Sell	1.9%	1 ratings

Out of 52 total stock ratings issued by Jailendra Singh at Truist Financial, the majority (50.0%) have been Buy recommendations, followed by 48.1% Hold and 1.9% Sell.

Best & Worst Calls

Best Call
000.0%
MCK
Jan 2022
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
ACCD
Jul 2021
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	53.8% of companies on NASDAQ	14 companies
NYSE	46.2% of companies on NYSE	12 companies

Jailendra Singh, an analyst at Truist Financial, currently covers 26 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 21 companies	80.8%
	Computer and Technology 2 companies	7.7%
	Finance 2 companies	7.7%
	Business Services 1 company	3.8%

Jailendra Singh of Truist Financial specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Finance companies.

Coverage Industries

Industry	Percentage
MEDICAL INFO SYS 7 companies	26.9%
MEDICAL SERVICES 6 companies	23.1%
INTERNET SOFTWARE 2 companies	7.7%
MED/DENTAL - SUPP 2 companies	7.7%
MISCELLANEOUS HEALTH & ALLIED SERVICES 2 companies	7.7%
MED INSTRUMENTS 1 company	3.8%
CUSTOM COMPUTER PROGRAMMING SERVICES 1 company	3.8%
MED - OUTP/HM CRE 1 company	3.8%
INS - LIFE 1 company	3.8%
INS - BROKERS 1 company	3.8%
BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED 1 company	3.8%
MED PRODUCTS 1 company	3.8%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
PHR Phreesia	9/5/2025	Boost Price Target	$28.09	$36.00	Buy
HIMS Hims & Hers Health	8/18/2025	Lower Price Target	$44.81	$37.00	Hold
ICLR Icon	7/25/2025	Boost Price Target	$185.50	$234.00	Buy
IQV IQVIA	7/23/2025	Boost Price Target	$192.44	$235.00	Buy
MEDP Medpace	7/23/2025	Boost Price Target	$449.28	$436.00	Hold
WAY Waystar	7/17/2025	Boost Price Target	$37.48	$51.00	Buy
PGNY Progyny	7/17/2025	Boost Price Target	$22.97	$27.00	Hold
HIMS Hims & Hers Health	7/17/2025	Boost Price Target	$51.50	$48.00	Hold
EVH Evolent Health	7/17/2025	Boost Price Target	$11.60	$16.00	Buy
DOCS Doximity	7/17/2025	Boost Price Target	$62.87	$61.00	Hold
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
HIMS Hims & Hers Health	6/24/2025	Set Price Target	$42.37	$45.00
HNGE Hinge Health	6/16/2025	Initiated Coverage	$34.76	$48.00	Buy
PHR Phreesia	5/29/2025	Boost Price Target	$23.93	$35.00	Buy
TDOC Teladoc Health	5/27/2025	Lower Price Target	$7.06	$9.00	Hold
DOCS Doximity	5/16/2025	Lower Price Target	$52.39	$52.00	Hold
WAY Waystar	5/7/2025	Set Price Target	$41.03	$50.00	Buy
MEDP Medpace	4/23/2025	Lower Price Target	$291.25	$300.00	Hold
MEDP Medpace	4/10/2025	Lower Price Target	$302.56	$333.00	Hold
IQV IQVIA	4/10/2025	Lower Price Target	$157.02	$216.00	Buy
ICLR Icon	4/10/2025	Lower Price Target	$155.49	$208.00	Buy
PRVA Privia Health Group	4/10/2025	Boost Price Target	$23.05	$28.00	Buy
HIMS Hims & Hers Health	4/10/2025	Lower Price Target	$29.39	$33.00	Hold
GDRX GoodRx	4/10/2025	Lower Price Target	$4.69	$5.50	Hold
EVH Evolent Health	4/10/2025	Lower Price Target	$9.98	$14.00	Buy
DOCS Doximity	4/10/2025	Lower Price Target	$55.59	$58.00	Hold
AMWL American Well	4/10/2025	Lower Price Target	$7.13	$7.50	Hold
ASTH Astrana Health	3/18/2025	Lower Price Target	$30.91	$46.00	Buy
WAY Waystar	3/14/2025	Initiated Coverage	$35.27	$45.00	Buy
HIMS Hims & Hers Health	2/26/2025	Boost Price Target	$39.95	$39.00	Hold
AMWL American Well	2/14/2025	Boost Price Target	$11.62	$12.00	Hold
ICLR Icon	2/13/2025	Lower Price Target	$186.53	$262.00	Buy
IQV IQVIA	2/10/2025	Reiterated Rating	$208.13	$263.00	Buy
ASTH Astrana Health	1/13/2025	Lower Price Target	$29.48	$50.00	Buy
VEEV Veeva Systems	1/13/2025	Lower Price Target	$215.73	$210.00	Hold

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.